Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline
VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificia… [+8165 chars]





